About us Pricing ContactSubscribe

M

Matti Lehtinen

Institute for Molecular Medicine FinlandORCID https://orcid.org/0000-0002-9481-0535

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

The Lancet Oncology20051,577 citations

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

British Journal of Cancer2006808 citations

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Vaccine2006465 citations

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

Vaccine2007455 citations